Header Logo

Connection

SANJAY MATHEW to Neurokinin-1 Receptor Antagonists

Back to Details
This is a "connection" page, showing publications SANJAY MATHEW has written about Neurokinin-1 Receptor Antagonists.
SANJAY MATHEW
Connection Strength
0.369
Neurokinin-1 Receptor Antagonists
  1. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur Neuropsychopharmacol. 2011 Mar; 21(3):221-9.
    View in: PubMed
    Score: 0.369
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.